LinkedIn, the social networking site for professionals that will soon be bought by Microsoft, is to be blocked in Russia after a local court ruled on Thursday that it had breached the country’s data protection rules, a sign of growing tensions for American tech companies operating in the country.
The case in the Moscow city courts arose at a time of debate in Washington over how the United States might retaliate for what American security officials said was the Russian government’s hacking of emails from the Democratic National Committee and other digital interference in the presidential election.
Russia has a history of increasing regulatory pressure on businesses in political disputes. The case began in August, before Donald J. Trump’s victory in Tuesday’s presidential election, and there is currently no connection between the LinkedIn case and the hacking scandal.
The country’s push to gain greater control over its internet users is one of a number of attempts by governments worldwide to dictate how people use digital services.
From China’s blocking of whole swaths of the internet to Europe’s efforts to regulate what can and cannot be viewed online, different regions and countries are in a battle with companies and other governments to decide how the internet will expand.
Russia imposed its ban — a rare occasion of LinkedIn being blocked in a country — after lawmakers passed new rules last year that required any personal digital data on Russian citizens collected by companies to be stored within the country.
Officials said the rules were aimed at protecting people’s online privacy from hackers, but critics have claimed the legislation could allow Russian authorities to force companies — both local and international — to hand over sensitive information about their users.
Full Content: New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas